Medicus Pharma announces 50-to-1 share consolidation effective October 12, 2026
Medicus Pharma Ltd. said it will consolidate its common shares on a 50-to-1 basis, effective October 12, 2026, with trading on a post-consolidation basis starting that day under the same ticker, MDCX. The company says the change is intended to raise the bid price of its shares and help it regain compliance with Nasdaq's minimum bid price requirement.
Key points
- Every 50 common shares will be exchanged for one new common share, effective October 12, 2026.
- Shareholders approved the consolidation, with a ratio of up to 50-to-1, at the June 3, 2026 annual meeting.
- Fractional shares will be rounded down and cash paid in lieu; the new CUSIP is 58471K301 and ticker stays MDCX.
The filing
Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 07, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.